Blume-Jensen Peter
President and CEO · 15 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-21 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 13,729 | $1.79 | $24,574.91 | filing |
| 2026-05-18 | ACRV | Acrivon Therapeutics, Inc. | Award | 180,095 | $0.00 | $0.00 | filing |
| 2026-05-18 | ACRV | Acrivon Therapeutics, Inc. | Award | 72,706 | $0.00 | $0.00 | filing |
| 2026-05-14 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 1,253 | $1.92 | $2,405.76 | filing |
| 2026-05-14 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 490 | $1.92 | $940.80 | filing |
| 2026-02-21 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 14,265 | $1.53 | $21,825.45 | filing |
| 2026-02-14 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 1,302 | $1.63 | $2,122.26 | filing |
| 2026-02-14 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 579 | $1.63 | $943.77 | filing |
| 2026-01-14 | ACRV | Acrivon Therapeutics, Inc. | Buy | 49,000 | $1.68 | $82,124.00 | filing |
| 2025-11-21 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 19,904 | $2.30 | $45,779.20 | filing |
| 2025-11-14 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 59,765 | $2.24 | $133,873.60 | filing |
| 2025-11-14 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 490 | $2.24 | $1,097.60 | filing |
| 2025-08-21 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 19,905 | $1.32 | $26,274.60 | filing |
| 2025-08-14 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 59,766 | $1.39 | $83,074.74 | filing |
| 2025-08-14 | ACRV | Acrivon Therapeutics, Inc. | Tax withholding | 490 | $1.39 | $681.10 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.